01 · SCIENCE
Some neural-cell clusters recovered after a delayed return from orbit
Phys.org says lab-grown neural-cell clusters sent to the ISS in 2024 returned late after bad weather. Some recovered slowly; later tests found nerve and glial cell development. The report does not say all survived.
Why it matters: The result may guide sample handling after spaceflight, but it is lab evidence, not a human treatment or proof microgravity improved the cells.
Read at Phys.org ↗
02 · WORLD
Pneumonia death at Russian institute remains under review
DW reports an Irkutsk anti-plague institute technician died. Authorities are investigating; regional officials said pneumonia, while national health officials denied a work-linked pathogen or special measures. Rubio called for transparency.
Why it matters: The death is confirmed, but the cause remains contested in the report. It does not establish an outbreak.
Read at DW ↗
03 · PUBLIC_LIFE
Alito says he intends to stay through the Supreme Court term
CNBC says Alito told Bloomberg he plans to serve through the current Supreme Court term, ending in June or July, and Bloomberg reports he ruled out lame-duck retirement. He announced no retirement.
Why it matters: A vacancy’s timing could affect Senate confirmation as control changes, but Alito’s remarks cover this term, not a retirement date.
Read at CNBC ↗
04 · PUBLIC_LIFE
Journalists seek safeguards in Trinidad and Tobago police law
The Guardian reports Trinidad and Tobago passed a police search-and-seizure bill on Sept. 24. The government cites crime; journalists seek safeguards for notebooks and devices, arguing press freedom is at risk.
Why it matters: Protection for reporting materials can affect source confidentiality; the public-safety case and journalists’ objection are separate claims.
Read at The Guardian ↗
05 · BUSINESS
Benchmark leads $25 million seed round for interceptor startup
TechCrunch reports Benchmark is leading a $25M seed into Furientis, which aims to mass-produce interceptors and holds a funded Pentagon contract. The round is Benchmark’s first pure defense bet; valuation reported secondhand.
Why it matters: The deal points to venture capital entering defense tech, but funding does not prove manufacturing scale or contract delivery.
Read at TechCrunch ↗